Systems, devices, and/or methods for managing transdermal patches
Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, activities that can comprise and/or relate to, controlling delivery of a transdermally-delivered medication, certain embodiments including a flux controller.
1. A system for manually controlling delivery of a transdermally-delivered medication, comprising:
a transdermal patch defining a delivery face, the transdermal patch configured to deliver medication to the skin of a patient;
a flux controller that is configured for the patient to selectively manually control a delivery flowrate of the medication to the skin of the patient from the delivery face of the transdermal patch; and
a medication-impermeable envelope configured to sealingly contain the transdermal patch and the flux controller;
wherein:
the flux controller defines at least one selectively patient-sizable medication-impermeable portion configured to define a predetermined reduction in a labeled medication flowrate for the transdermal patch;
the flux controller is non-destructively removeably adhered to a backing;
the flux controller is configured to be non-destructively manually removed by the patient from the backing prior to being paired by the patient with the transdermal patch;
the transdermal patch is configured to be attached to the skin;
the flux controller is configured to be located between the skin and a portion of the transdermal patch;
the flux controller has a skin-adhering adhesive attached thereto; and
the flux controller has a transdermal patch-adhering adhesive attached thereto.
2. A system for manually controlling delivery of a transdermally-delivered medication from a transdermal patch that defines a delivery face, the transdermal patch configured to deliver medication to the skin of a patient, the system comprising:
a flux controller that is configured for the patient to selectively manually control a delivery flowrate of the medication to the skin of the patient from the delivery face of the transdermal patch;
wherein:
the flux controller defines at least one selectively patient-sizable medication-impermeable portion configured to define a predetermined reduction in a labeled medication flowrate for the transdermal patch.
3. The system of claim 2 , wherein:
the flux controller is non-destructively removeably adhered to a backing.
4. The system of claim 2 , wherein:
the flux controller is configured to be non-destructively removed, from a backing to which it is adhered, prior to being paired with the transdermal patch.
5. The system of claim 2 , wherein:
the transdermal patch is configured to be attached to the skin.
6. The system of claim 2 , wherein:
the flux controller is configured to be attached to the skin.
7. The system of claim 2 , wherein:
the flux controller is configured as a medication-impermeable layer.
8. The system of claim 2 , wherein:
the flux controller is configured as a medication-impermeable layer having a skin-adhering adhesive attached thereto.
9. The system of claim 2 , wherein:
the flux controller is configured as a medication-impermeable layer having a transdermal patch-adhering adhesive attached thereto.
10. The system of claim 2 , further comprising:
the transdermal patch.
11. The system of claim 2 , further comprising:
a medication-impermeable envelope configured to sealingly contain the transdermal patch and the flux controller.
12. A system for manually controlling delivery of a transdermally-delivered medication, comprising:
a flux controller that is configured for a patient to selectively manually control a delivery flowrate of the medication to skin of the patient from a delivery face of a skin-attachable transdermal patch;
wherein:
the flux controller defines a patient-adjustably-sizable medication-impermeable portion configured to be manually sized to prevent the medication from flowing therethrough from the transdermal patch to the skin at a patient-adjustable fraction of a labeled medication flowrate for the transdermal patch.
13. The system of claim 12 , wherein:
the flux controller comprises a medication-impermeable layer.
14. The system of claim 12 , wherein:
the flux controller comprises a medication-permeable adhesive layer.
15. The system of claim 12 , wherein:
the flux controller comprises a medication-permeable portion.
16. The system of claim 12 , further comprising:
the transdermal patch.